NCT01106794 Molecular Analysis of Samples From Patients With Diffuse Intrinsic Pontine Glioma and Brainstem Glioma
| NCT ID | NCT01106794 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's National Research Institute |
| Condition | Diffuse Intrinsic Pontine Glioma |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2010-04 |
| Primary Completion | 2025-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2010-04 with a primary completion date of 2025-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to prospectively collect specimens from pediatric patients with diffuse intrinsic pontine glioma or brainstem glioma, either during therapy or at autopsy, in order to characterize the molecular abnormalities of this tumor.
Eligibility Criteria
Inclusion Criteria: * Patients of any age with clinical and radiologic diagnosis of diffuse intrinsic pontine glioma * Patients with other high-grade gliomas originating in the brainstem * Patients with focal gliomas (WHO grade I/II) of the brainstem Exclusion Criteria: * Patients with any type of infiltrative low grade (WHO grade I and II) or high grade glioma (WHO grade III and IV) originating outside the brainstem * Patients harboring primary brainstem tumors with other histologic diagnoses (e.g., PNET)
Contact & Investigator
Javad Nazarian, PhD
PRINCIPAL INVESTIGATOR
Children's National Research Institute
Frequently Asked Questions
Who can join the NCT01106794 clinical trial?
This trial is open to participants of all sexes, up to 21 Years, studying Diffuse Intrinsic Pontine Glioma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01106794 currently recruiting?
Yes, NCT01106794 is actively recruiting participants. Contact the research team at JNazarian@cnmc.org for enrollment information.
Where is the NCT01106794 trial being conducted?
This trial is being conducted at Washington D.C., United States.
Who is sponsoring the NCT01106794 clinical trial?
NCT01106794 is sponsored by Children's National Research Institute. The principal investigator is Javad Nazarian, PhD at Children's National Research Institute. The trial plans to enroll 100 participants.